BAROS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Baros, and what generic alternatives are available?
Baros is a drug marketed by Mallinckrodt Inc and is included in one NDA.
The generic ingredient in BAROS is sodium bicarbonate; tartaric acid. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium bicarbonate; tartaric acid profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for BAROS?
- What are the global sales for BAROS?
- What is Average Wholesale Price for BAROS?
Summary for BAROS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 206 |
| DailyMed Link: | BAROS at DailyMed |
US Patents and Regulatory Information for BAROS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt Inc | BAROS | sodium bicarbonate; tartaric acid | GRANULE, EFFERVESCENT;ORAL | 018509-001 | Aug 7, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
